A minimally invasive procedure to replace the aortic heart valve is superior to open surgery for patients with an intermediate risk of complications, according to a study that could pave the way for wider use of the approach. Patients who received the less-invasive implant had fewer strokes and a lower mortality rate after one year than those whose valve was replaced through open heart surgery, the Sapien 3 study showed.
The procedure, called transcatheter aortic valve replacement (TAVR), is currently available only for patients considered unlikely to survive open heart surgery or at high risk for complications. The new data, presented Sunday at the American College of Cardiology meeting in Chicago, will be used to ...
Also read: Brooks Koepka wins second straight US Open